Neurofilament light chain and C reactive protein explored as predictors of survival in amyotrophic lateral sclerosis
- 6 February 2020
- journal article
- letter
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 91 (4) , 436-437
Abstract
Levels of neurofilament light chain (NfL) and C reactive protein (CRP) are both altered in serum of patients with ALS.3 4 Interestingly, these markers are linked to functional disability and survival in ALS.3 4Keywords
Funding Information
- ALS Liga België
- KU Leuven funds “een Hart voor ALS”, “Laeversfonds voor ALS Onderzoek” and “the Valéry Perrier Race against ALS fund
- a Start-up grant of the Group of Biomedical Sciences KU Leuven
- Flemish Fund for Scientific Research (11E6319N, T003519N)
- Clinical Research Fund of the University Hospitals Leuven
- Rotary “Espoir en Tête – Hoofdzaak er is Hoop”
This publication has 4 references indexed in Scilit:
- Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral SclerosisNeuropathology and Applied Neurobiology, 2018
- Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction modelThe Lancet Neurology, 2018
- Serum C-Reactive Protein as a Prognostic Biomarker in Amyotrophic Lateral SclerosisJAMA Neurology, 2017
- Prognostic factors in ALS: A critical reviewAmyotrophic Lateral Sclerosis, 2009